Skip to main content
Log in

Falls in ambulatory non-demented patients with Parkinson’s disease

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

This study aimed at determining the prevalence of falling in PD patients, to assess generic and disease-specific clinical and pharmacological factors, relationship with health-related quality of life (HR-QoL) and changes in falls from OFF to ON in patients with motor fluctuations. Six-hundred and eighty-three PD patients of the COPARK survey were evaluated (11 had missing data and were excluded from the analysis). Patients with falls were identified as those with a UPDRS Item 13 ≥ 1 in the ON condition. All patients were assessed in a standardized manner [demographics, treatments, Unified PD Rating Scale (UPDRS), Hospital Anxiety and Depression Scale, Pittsburg questionnaire and HR-QoL scales (SF36, PDQ39)]. Falling was reported by 108/672 (16 %) PD patients during the ON state and prevalence increased according to PD severity, from 5 % in Hoehn and Yahr stage 1–60 % in stage 4. Falling was significantly related to lower HR-QoL. Falling correlated with (1) generic factors such as female gender, age at the end of academic studies and diuretics consumption, (2) motor PD-specific factors including disease severity, frozen gait, difficulties when arising from a chair, dyskinesia and higher levodopa daily equivalent dose and (3) non-motor PD-specific factors such as orthostatic hypotension and hallucinations. Falling was more frequent in OFF than in ON in 48/74 (64 %) patients with motor fluctuations and remained unchanged in 27 patients (36 %). In summary, falling affected a significant proportion of PD patients, especially in advanced stages. It was associated with a variety of generic and PD-specific factors and was related to reduced HR-QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis 2013:906274. doi:10.1155/2013/906274

    PubMed Central  PubMed  Google Scholar 

  • Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19(8):871–884. doi:10.1002/mds.20115

    Article  PubMed  Google Scholar 

  • Burrows S, Auger N, Gamache P, Hamel D (2012) Individual and area socioeconomic inequalities in cause-specific unintentional injury mortality: 11-year follow-up study of 2.7 million Canadians. Accid Anal Prev 45:99–106. doi:10.1016/j.aap.2011.11.010

    Article  PubMed  Google Scholar 

  • Cheng KY, Lin WC, Chang WN, Lin TK, Tsai NW, Huang CC, Wang HC, Huang YC, Chang HW, Lin YJ, Lee LH, Cheng BC, Kung CT, Chang YT, Su CM, Chiang YF, Su YJ, Lu CH (2014) Factors associated with fall-related fractures in Parkinson’s disease. Parkinsonism Relat Disord 20(1):88–92. doi:10.1016/j.parkreldis.2013.09.024

    Article  PubMed  Google Scholar 

  • Clubb VJ, Clubb SE, Buckley S (2006) Parkinson’s disease patients who fracture their neck of femur: a review of outcome data. Injury 37(10):929–934. doi:10.1016/j.injury.2005.11.013

    Article  CAS  PubMed  Google Scholar 

  • Coelho M, Marti MJ, Tolosa E, Ferreira JJ, Valldeoriola F, Rosa M, Sampaio C (2010) Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol 257(9):1524–1532. doi:10.1007/s00415-010-5566-8

    Article  PubMed  Google Scholar 

  • Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

    Article  PubMed  Google Scholar 

  • Hiorth YH, Lode K, Larsen JP (2013) Frequencies of falls and associated features at different stages of Parkinson’s disease. Eur J Neurol 20(1):160–166. doi:10.1111/j.1468-1331.2012.03821.x

    Article  CAS  PubMed  Google Scholar 

  • Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1995) Self-reported functioning and well-being in patients with Parkinson’s disease: comparison of the short-form health survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39). Age Ageing 24(6):505–509

    Article  CAS  PubMed  Google Scholar 

  • Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA (2010) Predictors of future falls in Parkinson disease. Neurology 75(2):116–124. doi:10.1212/WNL.0b013e3181e7b688

    Article  CAS  PubMed  Google Scholar 

  • Matinolli M, Korpelainen JT, Korpelainen R, Sotaniemi KA, Myllyla VV (2009) Orthostatic hypotension, balance and falls in Parkinson’s disease. Mov Disord 24(5):745–751. doi:10.1002/mds.22457

    Article  PubMed  Google Scholar 

  • Matinolli M, Korpelainen JT, Sotaniemi KA, Myllyla VV, Korpelainen R (2011) Recurrent falls and mortality in Parkinson’s disease: a prospective two-year follow-up study. Acta Neurol Scand 123(3):193–200. doi:10.1111/j.1600-0404.2010.01386.x

    Article  CAS  PubMed  Google Scholar 

  • Michalowska M, Fiszer U, Krygowska-Wajs A, Owczarek K (2005) Falls in Parkinson’s disease. Causes and impact on patients’ quality of life. Funct Neurol 20(4):163–168

    PubMed  Google Scholar 

  • Nemanich ST, Duncan RP, Dibble LE, Cavanaugh JT, Ellis TD, Ford MP, Foreman KB, Earhart GM (2013) Predictors of gait speeds and the relationship of gait speeds to falls in men and women with Parkinson disease. Parkinsons Dis 2013:141720. doi:10.1155/2013/141720

    PubMed Central  PubMed  Google Scholar 

  • Okuma Y (2014) Proceedings of MDPD 2013 freezing of gait and falls in Parkinson’s disease. J Parkinsons Dis 4(2):255–260. doi:10.3233/jpd-130282

    PubMed  Google Scholar 

  • Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Senard JM, Pavy-Le Traon A, Montastruc JL, Rascol O (2012) Factors related to orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord 18(5):501–505. doi:10.1016/j.parkreldis.2012.01.012

    Article  PubMed  Google Scholar 

  • Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destee A, Meissner WG, Schelosky L, Tison F, Rascol O (2014) Freezing of gait in parkinson’s disease: prevalence, determinants, and effects on quality of life. JAMA Neurol 71(7):884–890

    Article  PubMed  Google Scholar 

  • Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22(13):1892–1900. doi:10.1002/mds.21598

    Article  PubMed  Google Scholar 

  • Revilla FJ, Larsh TR, Mani A, Duker AP, Cox C, Succop P, Gartner M, Jarrin Tejada C, Bhattacharya A (2013) Effect of dopaminergic medication on postural sway in advanced Parkinson’s disease. Front Neurol 4:202. doi:10.3389/fneur.2013.00202

    Article  PubMed Central  PubMed  Google Scholar 

  • Rossi-Izquierdo M, Basta D, Rubio-Rodriguez JP, Santos-Perez S, Ernst A, Sesar-Ignacio A, Alberte-Woodward M, Amo MG, Estany-Gestal A, Roman-Rodriguez ES, Faraldo-Garcia A, Zubizarreta-Gutierrez A, Soto-Varela A (2014) Is posturography able to identify fallers in patients with Parkinson’s disease? Gait Posture. doi:10.1016/j.gaitpost.2014.02.003

    PubMed  Google Scholar 

  • Rudzinska M, Bukowczan S, Stozek J, Zajdel K, Mirek E, Chwala W, Wojcik-Pedziwiatr M, Banaszkiewicz K, Szczudlik A (2013) The incidence and risk factors of falls in Parkinson disease: prospective study. Neurol Neurochir Pol 47(5):431–437

    CAS  PubMed  Google Scholar 

  • Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. doi:10.1002/mds.23429

    Article  PubMed  Google Scholar 

  • van der Marck MA, Klok MP, Okun MS, Giladi N, Munneke M, Bloem BR (2013) Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson’s disease. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2013.10.030

    PubMed  Google Scholar 

  • Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC (2012) Fall frequency and risk assessment in early Parkinson’s disease. Parkinsonism Relat Disord 18(7):837–841. doi:10.1016/j.parkreldis.2012.04.004

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483

    Article  PubMed  Google Scholar 

  • Wood BH, Bilclough JA, Bowron A, Walker RW (2002) Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72(6):721–725

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the patients who agreed to participate in this study and the Association France-Parkinson for its support. The project was co-funded by unrestricted and unconditional grants from the Association France-Parkinson, ADREN, Boehringer Ingelheim, Eisai, Faust Pharmaceuticals, GlaxoSmithKline, Pierre Fabre Médicaments, Solvay Pharma, Wyeth Lederlé. The project was sponsored and co-financed by LN PHARMA, which participated into the design and conduct of the study; collection, management, and interpretation of the data; and preparation and review of the manuscript.

Conflict of interest

Olivier Rascol reports no disclosures, Santiago Perez-Lloret reports no disclosures, Philippe Damier reports no disclosures, Arnaud Delval reports no disclosures, Pascal Derkinderen reports no disclosures, Alain Destée reports no disclosures, Wassilios Meissner reports that a grant was received by the Bordeaux University Hospital for the project. Francois Tison reports no disclosures, Laurence Negre-Pages reports grants from the Association France-Parkinson, ADREN, Boehringer Ingelheim, Eisai, Faust Pharmaceuticals, GlaxoSmithKline, Pierre Fabre Médicaments, Solvay Pharma, Wyeth Lederlé for funding this project and that she owns stock options from LN PHARMA, which was one of the sponsors of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Rascol.

Appendix: List of the French neurologists who participated into the patients’ selection and data collection

Appendix: List of the French neurologists who participated into the patients’ selection and data collection

Author

Degree

Affiliation

F. Tison

MD

University Hospital Bordeaux

W. G. Meissner

MD

University Hospital Bordeaux

U. Spampinato

MD

University Hospital Bordeaux

P. Damier

MD

University Hospital Nantes

P. Derkinderen

MD

University Hospital Nantes

O. Rascol

MD

University Hospital Toulouse

V. Rey-Zermati

MD

General Hospital Narbonne

X. Soulages

MD

General hospital Rodez

C. Azais-Vuillemin

MD

Clinique du Parc, Toulouse

N. Stambouli

MD

General Hospital, Cahors

J. R. Rouane

MD

Clinique Pasteur, Toulouse

A. M. Salandini

MD

Clinique Pasteur, Toulouse

J. M. Boulesteix

MD

General Hospital, Cahors

M. Barreda

MD

Clinique Toulouse Lautrec, Castres

D. Castan

MD

General Hospital Castres

A. Ojero-Senard

MD

University Hospital Toulouse

S. Perez-Lloret

MD

University Hospital Toulouse

G. Angibaud

MD

Clinique pont-de-Chaume, Montauban

J. P. Balague

MD

Clinique pont-de-Chaume, Montauban

A. Danielli

MD

Hopital General, Montauban

N. Attane

MD

Hopital Général, Carcasonne

J. M. Faucheux

MD

Hopital Général, Castres

P. Henry

MD

Clinique Ambroise Paré, Toulouse

M.H Rougie

MD

Private Office Toulouse

B. Jardillier

MD

General hospital Figeac

F Azais

MD

Private Office, Toulouse

L Damase

MD

Private Office, Toulouse

A. Destee

MD

University Hospital Lille

P. Lejeune

MD

Hopital Départemental La- Roche-sur-Yon

JM Delabrousse-Mayoux

MD

Private Office, Bergerac

S. Bonenfant

BSc

University Hospital Toulouse

R. Darmanaden

MD

Hopital Général, Villefranche de Rouergue

A. Robinson

MD

Hopital Général, Carcasonne

E. Gaujard

MD

Private Office, Bordeaux

E. Puymirat

MD

Clinique saint-Augustin, Bordeaux

C. E. Goumard

MD

Private Office, Bordeaux

M. H. Godin

MD

Private Office, Bordeaux

C. Latxague

PhD

University of Bordeaux

C. Deligny

MD

Private practice, Nantes

T. Lebouvier

MD

University Hospital Nantes

C. Lanctin-Garcia

MD

Private practice, Nantes

M. Roy

BSc

University Hospital Nantes

V. Verbist-Talmant

MD

University Hospital Nantes

P. Bertout

MD

Private practice, Saint Nazaire

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rascol, O., Perez-Lloret, S., Damier, P. et al. Falls in ambulatory non-demented patients with Parkinson’s disease. J Neural Transm 122, 1447–1455 (2015). https://doi.org/10.1007/s00702-015-1396-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-015-1396-2

Keywords

Navigation